Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Ecchymosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Epistaxis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Menorrhagia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Prolonged bleeding time
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased tendency to bruise
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diabetes
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis.
|
12540964 |
2003 |
Diabetes Mellitus
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis.
|
12540964 |
2003 |
Ischemic stroke
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Ischaemic strokes and homozygosity for the alpha2 807T allele of the platelet collagen receptor in young monozygotic twins.
|
12544734 |
2003 |
Sarcoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Sarcoma family kinases (SFK) play central role in the GPVI-induced signaling pathway.
|
31683623 |
2019 |
Malignant neoplasm of soft tissue
|
0.010 |
Biomarker
|
group |
BEFREE |
Sarcoma family kinases (SFK) play central role in the GPVI-induced signaling pathway.
|
31683623 |
2019 |
Myeloproliferative disease
|
0.010 |
AlteredExpression
|
group |
BEFREE |
GPVI and alpha 2 beta 1 levels were found to be significantly decreased on platelets from patients with myeloproliferative disorders (MPDs).
|
12829582 |
2003 |
Hepatitis C
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
GPVI may be a platelet surface ligand for HCV playing a role in viral transport and persistence.
|
16847120 |
2006 |
Atherothrombosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
GPVI (Glycoprotein VI) is the essential platelet collagen receptor in atherothrombosis.
|
28751543 |
2017 |
Platelet thrombus
|
0.020 |
Biomarker
|
disease |
BEFREE |
GPVI-CD39 effectively stimulated local ADP degradation and, compared with GPVI-Fc alone, led to significantly increased inhibition of ADP-, collagen-, and human plaque-induced platelet aggregation in Multiplate aggregometry and plaque-induced platelet thrombus formation under arterial flow conditions.
|
28751543 |
2017 |
Atherothrombosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
Platelet glycoprotein VI (GPVI) acts as a decisive collagen receptor in atherothrombosis.
|
29378359 |
2018 |
Blood Coagulation Disorders
|
0.060 |
GeneticVariation
|
group |
BEFREE |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
|
19552682 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.
|
12515812 |
2003 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
A monoclonal antibody to GPIV alone inhibited tumor cell attachment to the heparin-domainless 140-kDa TSP fragment.
|
1703153 |
1991 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A significant association between GP VI 13254C allele carriers and premature MI was found (p=0.025).
|
19786296 |
2010 |
Glycoprotein VI deficiency
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |